申请人:Merck & Co., Inc.
公开号:EP0272866A1
公开(公告)日:1988-06-29
Aromatic 1,4-benzodiazepines with fused 5-membered heterocyclic rings which are antagonists of cholecystokinins and/or gastrin, and are useful in the treatment or prevention of CCK-related and/or gastrin-related disorders of the gastrointestinal, central nervous and appetite regulatory systems; compositions comprising these compounds; and methods of treatment in mammals and of increasing food intake of animals employing these compounds.
含有融合5元杂环环的芳香族1,4-苯二氮平,它们是胆囊收缩素和/或胃泌素的拮抗剂,可用于治疗或预防胃泌素相关和/或胆囊收缩素相关的胃肠道,中枢神经和食欲调节系统疾病;包括这些化合物的组合物;以及使用这些化合物治疗哺乳动物和增加动物进食的方法。